Basha_2018_Mol.Pharm_15_2206

Reference

Title : New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of beta-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase - Basha_2018_Mol.Pharm_15_2206
Author(s) : Basha SJ , Mohan P , Yeggoni DP , Babu ZR , Kumar PB , Rao AD , Subramanyam R , Damu AG
Ref : Mol Pharm , 15 :2206 , 2018
Abstract :

In line with the modern multi-target-directed ligand paradigm of Alzheimer's disease (AD), a series of 19 compounds composed of flavone and cyanoacetamide groups have been synthesized and evaluated as multifunctional agents against AD. Biological evaluation demonstrated that compounds 7j, 7n, 7o, 7r, and 7s exhibited excellent inhibitory potency (AChE, IC50 of 0.271 +/- 0.012 to 1.006 +/- 0.075 muM) and good selectivity toward acetylcholinesterase, significant antioxidant activity, good modulation effects on self-induced Abeta aggregation, low cytotoxicity, and neuroprotection in human neuroblastoma SK-N-SH cells. Further, an inclusive study on the interaction of 7j, 7n, 7o, 7r, and 7s with AChE at physiological pH 7.2 using fluorescence, circular dichroism, and molecular docking methods suggested that these derivatives bind strongly to the peripheral anionic site of AChE mostly through hydrophobic interactions. Overall, the multifunctional profiles and strong AChE binding affinity highlight these compounds as promising prototypes for further pursuit of innovative multifunctional drugs for AD.

PubMedSearch : Basha_2018_Mol.Pharm_15_2206
PubMedID: 29745222

Related information

Citations formats

Basha SJ, Mohan P, Yeggoni DP, Babu ZR, Kumar PB, Rao AD, Subramanyam R, Damu AG (2018)
New Flavone-Cyanoacetamide Hybrids with a Combination of Cholinergic, Antioxidant, Modulation of beta-Amyloid Aggregation, and Neuroprotection Properties as Innovative Multifunctional Therapeutic Candidates for Alzheimer's Disease and Unraveling Their Mechanism of Action with Acetylcholinesterase
Mol Pharm 15 :2206

Basha SJ, Mohan P, Yeggoni DP, Babu ZR, Kumar PB, Rao AD, Subramanyam R, Damu AG (2018)
Mol Pharm 15 :2206